Home health testing provider YorkTest has reported a record year of business following an unprecedented 50% increase in annual sales.

The company is now estimated to have reached £6 million turnover, making it one the UK’s most successful ventures into this niche market!

Based in York, the company is one of the UK’s leading suppliers of home-to-laboratory health tests, including food intolerance and allergy testing, as well as offering traditional blood chemistry tests such as liver function, cholesterol, menopause, diabetes, thyroid, inflammation, and stress tests.

YorkTest has put the growth down to the recent boom in home health testing and has increased its headcount of scientists by 20% over the last 12 months to meet demand. This expansion and recruitment drive is expected to continue for the next few years.

Richard Dawson, CEO at YorkTest Laboratories Ltd, said:

“The challenges of the past couple of years have led to more people than ever taking control of their own health, nutrition and wellbeing.  This shift has seen a marked increase in demand for home health tests, during a time when the NHS has been at its most stretched and access to healthcare limited during lockdowns.

“Consumers are also becoming more confident in taking control of their own health, following their experiences over the past two years during the pandemic, and this is reflected in changing buying behaviour and the rise in online sales across our portfolio of home health tests.”

The company has also seen a substantial increase in sales in the United States, where demand for its food sensitivity tests increased ten-fold in 2021 compared to previous years.

Dawson added: 

“Growing the US market has been an exciting project for YorkTest and we have been fortunate that customers recognise YorkTest’s 40-year scientific history, specialist testing laboratory experience and the expert nutritional therapist consultations provided with all our food intolerance tests.

“In the UK, we are delighted to partner with a growing number of corporate customers, as employers look to provide support and guidance around health and wellbeing for their people. YorkTest makes the provision of private health testing affordable to millions of employees across the UK, whereas until recently such benefits were only afforded to company executives.

“It’s estimated that the home health testing market will be worth $8.15bn by 2030, and YorkTest is well-positioned to contribute to this booming industry, with significant investment in cloud-based technology, leading laboratory equipment, and expertise at the core. We have another busy year ahead and will be launching more products in the coming months, including several wellness, hormone, and fertility-specific tests.”

YorkTest is backed by private equity firm Key Capital Partners, which has supported the management team during its transition from a specialist food intolerance testing company to a wider home health testing business.